All lobbying filings
ASTELLAS PHARMA US, INC.
ASTELLAS PHARMA US, INC. filed a Q3 report for ASTELLAS PHARMA US, INC. on October 20, 2026.
Lobbying for ASTELLAS PHARMA US, INC.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Expenses
$480,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Illinois
Lobbyists on this filing
1
-
HAYLEY ALEXANDER New on this filingPreviously held: Professional Staff Member, Senate Committee on Appropriations Scheduler and Press Assistant, Congressman Justin Amash Special Assistant for Constituent Services, Congressman Gregg Harper
Government bodies contacted
4
Lobbying activity
4
Issues pertaining to Medicare Part D; Issues related to the Inflation Reduction Act (Pub. L. 117-169); Issues related to OBBA (Pub. L. No: 119-21).
Issues related to Women's Health and Menopause (no specific bills); Issues related to Eye Screening and Access (no specific bills); Issues related to implementation of the Inflation Reduction Act (Pub. L. 117-169); Issues Related to OBBA (Pub. L. No: 119-21); Issues related to health care transparency.
Issues related to IP/Bayh-Dole Act (Pub.L. 96-517).
Issues related to OBBA (Pub. L. No: 119-21).